The developer of an extracorporeal blood-cleansing device designed to selectively remove pathogens, including multi-drug resistant bacteria and endotoxins from circulating blood. The company's blood cleansing device selectively separates and captures bacteria from human blood for the treatment of blood-borne infection sepsis. This enables health professionals to eliminate intact bacteria from the blood rather than trying to kill the infection.

Their technology aids in the diagnosis and treatment of sepsis. The device significantly reduces pathogen and endotoxin levels, which has been validated in preclinical studies. It also represents a novel, promising strategy for immediate treatment in bacteremia and sepsis.